Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > Pro-forma financials
View:
Post by lscfa on Feb 15, 2024 10:30pm

Pro-forma financials

Gagnon blew $6.7M of cash on this lousy merger......

4 (d) To reflect the payment of $2,766,181 estimated non-recurring incremental transaction costs of Ceapro, including banking, printing, legal and accounting services which are incremental cost of the Transaction, that are not recorded in its September 30, 2023 financial statements as an increase to general and administrative expense as if the transactions had occurred on September 30, 2023. The transaction is not expected to have a recurring impact. 

 

4 (e)    To reflect the payment of $3,949,398 estimated non-recurring incremental transaction costs of Aeterna Zentaris, including banking, printing, legal and accounting services which are incremental cost of the Transaction, that are not recorded in its September 30, 2023 financial statements as an increase to general and administrative expense as if the transactions had occurred on September 30, 2023. The transaction is not expected to have a recurring impact. 

 

Comment by lscfa on Feb 15, 2024 10:33pm
That's $6.7M additional cash blown. CZO has already spent $1.5M on legal for 9 months ended Sept 30/23
Comment by Ciao on Feb 15, 2024 10:35pm
There would be likely grounds for a lawsuit.
Comment by Ciao on Feb 15, 2024 10:52pm
Now I understand the sense of desparation in the NR today where an anonymous director asks to vote yes as time is short. The costs for this M&A seem very high. https://www.ey.com/en_us/strategy-transactions/four-current-trends-estimating-mergers-acquisitions-integration-costs#:~:text=M%26A%20transaction%20costs%20can%20range,according%20to%20the%20EY%20analysis. does 4(e) indicate we are ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities